Differential generalization to pentobarbital in rats trained to discriminate lorazepam, chlordiazepoxide, diazepam, or triazolam-Reference-Cited by-同舟云学术

Differential generalization to pentobarbital in rats trained to discriminate lorazepam, chlordiazepoxide, diazepam, or triazolam

Published:1989-05 Issue:1 Volume:98 Page:20-30
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Ator Nancy A.,Griffiths Roland R.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/BF00442001.pdf

Reference53 articles.

1. Ator NA (1989) Drug stimulus discrimination and drug stimulus generalization with anxiolytics. Drug Dev Res (in press)

2. Ator NA, Griffiths RR (1983) Lorazepam and pentobarbital drug discrimination in baboons: Cross-drug generalization tests and interaction with Ro 15-1788. J Pharmacol Exp Ther 226:776?782

3. Ator NA, Griffiths RR (1985a) Asymmetrical cross-generalization in lorazepam (LOR)-and pentobarbital (PB)-trained rats. Fed Proc 44:495

4. Ator NA, Griffiths RR (1985b) Lorazepam and pentobarbital discrimination: Interactions with CGS 8216 and caffeine. Eur J Pharmacol 107:169?181

5. Ator NA, Griffiths RR (1986) Discriminative stimulus effects of atypical anxiolytics in baboons and rats. J Pharmacol Exp Ther 237:393?403

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central Nervous System (CNS) Safety Pharmacology Studies;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2022

2. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB 1 receptor-mediated discriminative stimulus in mice;Neuropharmacology;2017-10

3. Current FDA regulatory guidance on the conduct of drug discrimination studies for NDA review: Does the scientific literature support recent recommendations?;Drug and Alcohol Dependence;2016-11

4. A translational pharmacology approach to understanding the predictive value of abuse potential assessments;Behavioural Pharmacology;2013-09

5. Central Nervous System (CNS) Safety Pharmacology Studies;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2013